{"entity":{"id":"binding-site-barrier","kind":"term","name":"Binding-site barrier in tumor delivery","aka":["binding site barrier","perivascular antibody trapping"],"tldr":"An antibody can bind so readily near a tumor's blood vessels that little reaches cells farther away. Strong binding and even delivery throughout a tumor are different properties.","summary":"Antibody uptake can be concentrated near accessible binding sites, leaving heterogeneous intratumoral distribution. A primary antibody-drug conjugate study altered antibody coadministration in a mouse xenograft model and improved penetration and efficacy without increasing the payload dose. This establishes a delivery mechanism in that model, not a dosing recommendation for patients. Distribution, retained binding and effective intracellular exposure need to be considered together.","asOf":"2026-11-08","links":[{"label":"Tumor penetration and single-cell conjugate targeting study (2018)","url":"https://doi.org/10.1158/0008-5472.CAN-17-1638"}],"tags":[],"related":["epitope","antigen-expression-and-response","experimental-versus-clinical-exposure"],"cancers":[],"sections":[],"technologies":["adc"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"category":"ADC chemistry"},"route":"/terms/binding-site-barrier/","neighbours":{"term":[{"id":"antigen-expression-and-response","kind":"term","name":"Antigen expression and treatment response","route":"/terms/antigen-expression-and-response/"},{"id":"epitope","kind":"term","name":"Epitope","route":"/terms/epitope/"},{"id":"measurement-to-benefit-evidence","kind":"term","name":"Evidence from measurement to patient benefit","route":"/terms/measurement-to-benefit-evidence/"},{"id":"experimental-versus-clinical-exposure","kind":"term","name":"Experimental and clinical drug exposure","route":"/terms/experimental-versus-clinical-exposure/"}],"technology":[{"id":"adc","kind":"technology","name":"Antibody-drug conjugate (ADC)","route":"/technologies/adc/"}]}}